Finance

Lists
Why is 069620 up २.७६%?
Dive Deeper
069620:KRX
Daewoong Pharma
₩ १,०७,९००.००
+२.७६%
(+२,९००.००) 1D
अक्टोबर १९, १३:५९:१२ GMT+९  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 069620...
Open
₩ १,०५,३००
High
₩ १,०८,५००
Low
₩ १,०४,०००
Mkt. cap
१२.५० खरब
Avg. vol.
१९.१८ हजार
Volume
१२.३१ हजार
Dividend
०.५६%
Quarterly dividend
₩ १५०
Ex-dividend date
२०२३ डिसेम्बर २७
P/E ratio
६.३५
52-wk high
₩ १,९९,४००
52-wk low
₩ १,०१,९००
EPS
₩ १६,९८८
Shares outstanding
१.१६ करोड
No. of employees
२ हजार
Open
₩ १,०५,३००
High
₩ १,०८,५००
Low
₩ १,०४,०००
Mkt. cap
१२.५० खरब
Avg. vol.
१९.१८ हजार
Volume
१२.३१ हजार
Dividend
०.५६%
Quarterly dividend
₩ १५०
Ex-dividend date
२०२३ डिसेम्बर २७
P/E ratio
६.३५
52-wk high
₩ १,९९,४००
52-wk low
₩ १,०१,९००
EPS
₩ १६,९८८
Shares outstanding
१.१६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
९ मिनेट पहिले
InterDigital (IDCC) Stock Looks Reasonably Priced On Royalty Earnings
Seeking Alpha
Seeking Alpha
·
३४ मिनेट पहिले
S&P 500 Earnings Yield Jumps Over 5%; Sold The EMXC
Bloomberg.com
Bloomberg.com
·
७ घण्टा पहिले
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
About Daewoong Pharma
CEOChang-jae Lee | Seongsoo Park
Employees१.८९ हजार
Founded१९४५
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.१२ खरब
३.९७ खरब
३.७८ खरब
४.४८ खरब
Cost of goods sold
१.९८ खरब
१.८६ खरब
१.९७ खरब
१.९९ खरब
Cost of revenue
१.९८ खरब
१.८६ खरब
१.९७ खरब
१.९९ खरब
Research and development expenses
८.३१ अरब
१.४० खरब
१६.११ अरब
१४.८१ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.४४ खरब
२३.१२ अरब
१.३७ खरब
१.५५ खरब
Operating expense
१.५७ खरब
१.६९ खरब
१.५९ खरब
१.८१ खरब
Total operating expenses
३.५५ खरब
३.५५ खरब
३.५६ खरब
३.८० खरब
Operating income
५६.८९ अरब
४२.०६ अरब
२२.२१ अरब
६८.०७ अरब
Other non operating income
-१.१६ अरब
२.७७ अरब
१.५२ अरब
-३६.५३ अरब
EBT including unusual items
५४.७३ अरब
६८.९७ अरब
३३.९७ अरब
२१.८९ अरब
EBT excluding unusual items
५४.७३ अरब
८८.०२ अरब
११.८२ अरब
२१.८९ अरब
Income tax expense
७.४२ अरब
-१६.७३ अरब
८.४६ अरब
१.९८ अरब
Effective tax rate
१३.५६%
-२४.२६%
२४.८९%
९.०२%
Other operating expenses
१.१७ अरब
१.१७ अरब
१.८८ अरब
१.६१ अरब
Net income
४६.३७ अरब
८९.८४ अरब
२५.९० अरब
३३.३७ अरब
Net profit margin
११.२६%
२२.६२%
६.८६%
७.४४%
Earnings per share
-
-
-
-
Interest and investment income
-
१.१२ अरब
१.७४ अरब
-
Interest expense
-
-३.५३ अरब
-८.०० अरब
-
Net interest expenses
-
-२.४१ अरब
-६.२६ अरब
-
Depreciation and amortization charges
१.७७ अरब
१.४३ अरब
१.१५ अरब
७.९४ अरब
EBITDA
६९.४५ अरब
५६.०४ अरब
३८.३८ अरब
९२.९५ अरब
Gain or loss from assets sale
-१.२८ करोड
-५२.३१ अरब
३.५० करोड
-७५.३७ लाख
AI content may include mistakes. Learn more
Google एपहरू